Hospital-based therapies for the management of acute, life-threatening neurological conditions. (NASDAQ: EDGE)
Total raised: $90.5M
Investors 1
| Date | Name | Website |
| - | Sofinnova ... | sofinnova.... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 09.04.2015 | - | $72.5M | - |
| 04.06.2013 | Series C | $18M | - |
Mentions in press and media 11
| Date | Title | Description |
| 29.06.2016 | The biotech IPO feast flags as investors lose their appetite for R&D risk | There was a time after the 2008 crash that biotech IPOs were about as popular as snow in March. But from 2013 through 2015 generalist investors got over their fears and jumped into one of the hottest stock games on the planet. Fund... |
| 09.04.2015 | A new treatment for brain aneurysm: Edge Therapeutics rakes in $72.5M | The new dollars will go toward wrapping up its Phase 1/2 NEWTON study and ramp up for a Phase 3 trial for EG-1962 to target ruptured brain aneurysms. Preliminary data from two of the six patient cohorts of the NEWTON study was favorable, Ed... |
| 09.04.2015 | Edge Therapeutics Raises $72.5M in Funding | Edge Therapeutics, a Berkeley Heights, N.J.-based clinical-stage biotechnology company, raised approximately $72.5m in funding. The proceeds came from two private financing rounds. The most recent round, a $56m Series C-2 financing, was com... |
| 09.04.2015 | Edge Therapeutics Raises $72.5M | BERKELEY HEIGHTS, NJ, Clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies for acute, life-threatening neurological conditions, today announced that it has raised approxi... |
| 08.09.2014 | Edge Therapeutics Receives up to $10M in Venture Debt Financing | Edge Therapeutics, a Berkeley Heights, NJ-based clinical-stage biotechnology company that develops therapies for treatment of acute, life-threatening neurological conditions, obtained up to $10m in venture debt financing. Hercules Technolog... |
| 04.10.2013 | From gamification to personalized medicine, here’s a list of companies pitching at IMPACT | CardioReady (@CardioReady) is all about automated external defibrillators and helps customers evaluate, buy, install, track, and maintain them. Healthper (@HealthPer) works with employer wellness plans using a mix of gamification and incent... |
| 13.08.2013 | Biopharma gets its first angel investment from NJ tax credit initiative | Edge Therapeutics raised $18 million in a Series C round in June to carry out a Phase 2 clinical study for the prevention of delayed cerebral ischemia, a life-threatening complication of subarachnoid hemorrhage. Delayed cerebral ischemia is... |
| 04.06.2013 | Edge Therapeutics Raises $18M in Series C Financing | Edge Therapeutics, Inc., a New Providence, NJ-based clinical-stage biopharmaceutical company, raised $18m in a Series C financing. Backers were not disclosed. It is known that Maxim Group LLC was the sole placement agent and financial advis... |
| - | A new treatment for brain aneurysm: Edge Therapeutics rakes in $72.5M | New Jersey biotech Edge Therapeutics just raised $72.5 million from two new financing rounds, with aims to advance its drug delivery system for brain hemorrhaging and other acute neurological conditions into Phase 3. Edge has two novel prod... |
| - | From gamification to personalized medicine, here’s a list of companies pitching at IMPACT | Identifying and tracking patients who are likely to be readmitted, gamification strategies for employer wellness programs and interoperability are a few of the technologies from startup and growth stage companies pitching at the IMPACT conf... |
Show more